Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

Onko-Sure in IRAN<<<>>SRL BREAST CANCER TEST IN ITALY

http://www.retenews24.it/rtn24/donna-2/prevenzione-tumori-creato-un-test-con-semplice-analisi-del-sangue-che-rivela-13-tipi-di-cancro-ecco-quale/




Prevention is the best weapon to defend themselves from cancer, but if this were not enough early diagnosis is fundamental to winning the battle against this evil.

In this regard has been developed a new diagnostic test, minimally invasive and expensive, able to discover the presence of 13 different types of cancer.

The test is carried out using a simple blood test, the analysis of which you can tell if cancer cells are present in the body, even if the eventual disease was in its early stages.

The exam, called Onko-Sure, it would be able to diagnose tumors in the colon, rectum, lung, liver, ovaries and many others.

To create it were the company's specialists SRL Diagnostics, led by Dr BR Das, which have concentrated on some protein fragments (FDP) that are produced from the degradation of fibrinogen.

The test allows you to track down these molecules that determine the action of cancer cells, and we hope to become, once implemented, an effective prevention tool available to all.


SRL is distributing Onko-Sure in EU including Italy, Spain, UK, Russia, Africa, Middle east, Turkey..etc. This is hw provista will get their Videssa Breast, Videssa Lung,to the market along with all the little piggies you understand etc..ahooooooooooooooooooooo


That's amore... L’analisi del sangue rileva 13 tipi di tumore

http://www.west-info.eu/it/analisi-del-sangue-13-tipi-tumore-cancro/2012-02-onkosure-fibrin-fdp-in-cancer-mm-2/

http://isna.ir/fa/news/91111508754/%D8%AA%D8%B4%D8%AE%DB%8C%D8%B5-13-%D9%86%D9%88%D8%B9-%D8%B3%D8%B1%D8%B7%D8%A7%D9%86-%D9%85%D8%AE%D8%AA%D9%84%D9%81-%D8%AA%D9%86%D9%87%D8%A7-%D8%A8%D8%A7-%DB%8C%DA%A9-%D8%A2%D8%B2%D9%85%D8%A7%DB%8C%D8%B4

http://www.asriran.com/fa/news/255614/%D8%AA%D8%B4%D8%AE%DB%8C%D8%B5-13-%D9%86%D9%88%D8%B9-%D8%B3%D8%B1%D8%B7%D8%A7%D9%86-%D9%85%D8%AE%D8%AA%D9%84%D9%81-%D8%AA%D9%86%D9%87%D8%A7-%D8%A8%D8%A7-%DB%8C%DA%A9-%D8%A2%D8%B2%D9%85%D8%A7%DB%8C%D8%B4-%D8%AE%D9%88%D9%86